カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の樹状細胞ワクチン市場予測2023-2029：非標的型、標的型

【英語タイトル】Dendritic Cell Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8450）・商品コード：MMG23LY8450
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の樹状細胞ワクチン市場規模と予測を収録しています。・世界の樹状細胞ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の樹状細胞ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の樹状細胞ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非標的型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

樹状細胞ワクチンのグローバル主要企業は、3M、 Activarti、 Argos Therapeutics、 Batavia Bioservices、 Bellicum Pharmaceuticals、 Creagene、 DanDrit Biotech、 DCPrime、 Sanpower Corporation (Dendreon Corporation)、 Elios Therapeutics、 ImmunoCellular Therapeutics、 Immunicum、 Kiromic、 Medigene、 Merck & Co.、 Northwest Biotherapeutics、 Glaxo Smith Kline、 Tella Incorporation、 Vaxil BioTherapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、樹状細胞ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の樹状細胞ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の樹状細胞ワクチン市場：タイプ別市場シェア、2022年
・非標的型、標的型

世界の樹状細胞ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の樹状細胞ワクチン市場：用途別市場シェア、2022年
・新型コロナウイルス感染症、がん、その他

世界の樹状細胞ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の樹状細胞ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における樹状細胞ワクチンのグローバル売上、2018年-2023年
・主要企業における樹状細胞ワクチンのグローバル売上シェア、2022年
・主要企業における樹状細胞ワクチンのグローバル販売量、2018年-2023年
・主要企業における樹状細胞ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
3M、 Activarti、 Argos Therapeutics、 Batavia Bioservices、 Bellicum Pharmaceuticals、 Creagene、 DanDrit Biotech、 DCPrime、 Sanpower Corporation (Dendreon Corporation)、 Elios Therapeutics、 ImmunoCellular Therapeutics、 Immunicum、 Kiromic、 Medigene、 Merck & Co.、 Northwest Biotherapeutics、 Glaxo Smith Kline、 Tella Incorporation、 Vaxil BioTherapeutics

*************************************************************

・調査・分析レポートの概要
樹状細胞ワクチン市場の定義
市場セグメント
世界の樹状細胞ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の樹状細胞ワクチン市場規模
世界の樹状細胞ワクチン市場規模：2022年 VS 2029年
世界の樹状細胞ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの樹状細胞ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の樹状細胞ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非標的型、標的型
樹状細胞ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：新型コロナウイルス感染症、がん、その他
樹状細胞ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別樹状細胞ワクチン市場規模 2022年と2029年
地域別樹状細胞ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
3M、 Activarti、 Argos Therapeutics、 Batavia Bioservices、 Bellicum Pharmaceuticals、 Creagene、 DanDrit Biotech、 DCPrime、 Sanpower Corporation (Dendreon Corporation)、 Elios Therapeutics、 ImmunoCellular Therapeutics、 Immunicum、 Kiromic、 Medigene、 Merck & Co.、 Northwest Biotherapeutics、 Glaxo Smith Kline、 Tella Incorporation、 Vaxil BioTherapeutics
...

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.
This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Vaccine. This report contains market size and forecasts of Dendritic Cell Vaccine in global, including the following market information:
Global Dendritic Cell Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dendritic Cell Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dendritic Cell Vaccine companies in 2022 (%)
The global Dendritic Cell Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-Targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Vaccine include 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime and Sanpower Corporation (Dendreon Corporation), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dendritic Cell Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, by Type, 2022 (%)
Non-Targeted
Target
Global Dendritic Cell Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, by Application, 2022 (%)
Covid-19
Cancer
Others
Global Dendritic Cell Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dendritic Cell Vaccine revenues share in global market, 2022 (%)
Key companies Dendritic Cell Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dendritic Cell Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.
Northwest Biotherapeutics
Glaxo Smith Kline
Tella Incorporation
Vaxil BioTherapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dendritic Cell Vaccine, market overview.
Chapter 2: Global Dendritic Cell Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Dendritic Cell Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dendritic Cell Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dendritic Cell Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dendritic Cell Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Vaccine Overall Market Size
2.1 Global Dendritic Cell Vaccine Market Size: 2022 VS 2029
2.2 Global Dendritic Cell Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dendritic Cell Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Dendritic Cell Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Vaccine Revenue by Companies
3.4 Global Dendritic Cell Vaccine Sales by Companies
3.5 Global Dendritic Cell Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dendritic Cell Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dendritic Cell Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Dendritic Cell Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dendritic Cell Vaccine Market Size Markets, 2022 & 2029
4.1.2 Non-Targeted
4.1.3 Target
4.2 By Type – Global Dendritic Cell Vaccine Revenue & Forecasts
4.2.1 By Type – Global Dendritic Cell Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Dendritic Cell Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Dendritic Cell Vaccine Sales & Forecasts
4.3.1 By Type – Global Dendritic Cell Vaccine Sales, 2018-2023
4.3.2 By Type – Global Dendritic Cell Vaccine Sales, 2024-2029
4.3.3 By Type – Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dendritic Cell Vaccine Market Size, 2022 & 2029
5.1.2 Covid-19
5.1.3 Cancer
5.1.4 Others
5.2 By Application – Global Dendritic Cell Vaccine Revenue & Forecasts
5.2.1 By Application – Global Dendritic Cell Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Dendritic Cell Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Dendritic Cell Vaccine Sales & Forecasts
5.3.1 By Application – Global Dendritic Cell Vaccine Sales, 2018-2023
5.3.2 By Application – Global Dendritic Cell Vaccine Sales, 2024-2029
5.3.3 By Application – Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dendritic Cell Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Dendritic Cell Vaccine Revenue & Forecasts
6.2.1 By Region – Global Dendritic Cell Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Dendritic Cell Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Dendritic Cell Vaccine Sales & Forecasts
6.3.1 By Region – Global Dendritic Cell Vaccine Sales, 2018-2023
6.3.2 By Region – Global Dendritic Cell Vaccine Sales, 2024-2029
6.3.3 By Region – Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dendritic Cell Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Dendritic Cell Vaccine Sales, 2018-2029
6.4.3 US Dendritic Cell Vaccine Market Size, 2018-2029
6.4.4 Canada Dendritic Cell Vaccine Market Size, 2018-2029
6.4.5 Mexico Dendritic Cell Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dendritic Cell Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Dendritic Cell Vaccine Sales, 2018-2029
6.5.3 Germany Dendritic Cell Vaccine Market Size, 2018-2029
6.5.4 France Dendritic Cell Vaccine Market Size, 2018-2029
6.5.5 U.K. Dendritic Cell Vaccine Market Size, 2018-2029
6.5.6 Italy Dendritic Cell Vaccine Market Size, 2018-2029
6.5.7 Russia Dendritic Cell Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Dendritic Cell Vaccine Market Size, 2018-2029
6.5.9 Benelux Dendritic Cell Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dendritic Cell Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Dendritic Cell Vaccine Sales, 2018-2029
6.6.3 China Dendritic Cell Vaccine Market Size, 2018-2029
6.6.4 Japan Dendritic Cell Vaccine Market Size, 2018-2029
6.6.5 South Korea Dendritic Cell Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Dendritic Cell Vaccine Market Size, 2018-2029
6.6.7 India Dendritic Cell Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dendritic Cell Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Dendritic Cell Vaccine Sales, 2018-2029
6.7.3 Brazil Dendritic Cell Vaccine Market Size, 2018-2029
6.7.4 Argentina Dendritic Cell Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dendritic Cell Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dendritic Cell Vaccine Sales, 2018-2029
6.8.3 Turkey Dendritic Cell Vaccine Market Size, 2018-2029
6.8.4 Israel Dendritic Cell Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Dendritic Cell Vaccine Market Size, 2018-2029
6.8.6 UAE Dendritic Cell Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Dendritic Cell Vaccine Major Product Offerings
7.1.4 3M Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Activarti
7.2.1 Activarti Company Summary
7.2.2 Activarti Business Overview
7.2.3 Activarti Dendritic Cell Vaccine Major Product Offerings
7.2.4 Activarti Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Activarti Key News & Latest Developments
7.3 Argos Therapeutics
7.3.1 Argos Therapeutics Company Summary
7.3.2 Argos Therapeutics Business Overview
7.3.3 Argos Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.3.4 Argos Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Argos Therapeutics Key News & Latest Developments
7.4 Batavia Bioservices
7.4.1 Batavia Bioservices Company Summary
7.4.2 Batavia Bioservices Business Overview
7.4.3 Batavia Bioservices Dendritic Cell Vaccine Major Product Offerings
7.4.4 Batavia Bioservices Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Batavia Bioservices Key News & Latest Developments
7.5 Bellicum Pharmaceuticals
7.5.1 Bellicum Pharmaceuticals Company Summary
7.5.2 Bellicum Pharmaceuticals Business Overview
7.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Major Product Offerings
7.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.6 Creagene
7.6.1 Creagene Company Summary
7.6.2 Creagene Business Overview
7.6.3 Creagene Dendritic Cell Vaccine Major Product Offerings
7.6.4 Creagene Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Creagene Key News & Latest Developments
7.7 DanDrit Biotech
7.7.1 DanDrit Biotech Company Summary
7.7.2 DanDrit Biotech Business Overview
7.7.3 DanDrit Biotech Dendritic Cell Vaccine Major Product Offerings
7.7.4 DanDrit Biotech Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 DanDrit Biotech Key News & Latest Developments
7.8 DCPrime
7.8.1 DCPrime Company Summary
7.8.2 DCPrime Business Overview
7.8.3 DCPrime Dendritic Cell Vaccine Major Product Offerings
7.8.4 DCPrime Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 DCPrime Key News & Latest Developments
7.9 Sanpower Corporation (Dendreon Corporation)
7.9.1 Sanpower Corporation (Dendreon Corporation) Company Summary
7.9.2 Sanpower Corporation (Dendreon Corporation) Business Overview
7.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Major Product Offerings
7.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Sanpower Corporation (Dendreon Corporation) Key News & Latest Developments
7.10 Elios Therapeutics
7.10.1 Elios Therapeutics Company Summary
7.10.2 Elios Therapeutics Business Overview
7.10.3 Elios Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.10.4 Elios Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Elios Therapeutics Key News & Latest Developments
7.11 ImmunoCellular Therapeutics
7.11.1 ImmunoCellular Therapeutics Company Summary
7.11.2 ImmunoCellular Therapeutics Dendritic Cell Vaccine Business Overview
7.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.12 Immunicum
7.12.1 Immunicum Company Summary
7.12.2 Immunicum Dendritic Cell Vaccine Business Overview
7.12.3 Immunicum Dendritic Cell Vaccine Major Product Offerings
7.12.4 Immunicum Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Immunicum Key News & Latest Developments
7.13 Kiromic
7.13.1 Kiromic Company Summary
7.13.2 Kiromic Dendritic Cell Vaccine Business Overview
7.13.3 Kiromic Dendritic Cell Vaccine Major Product Offerings
7.13.4 Kiromic Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Kiromic Key News & Latest Developments
7.14 Medigene
7.14.1 Medigene Company Summary
7.14.2 Medigene Business Overview
7.14.3 Medigene Dendritic Cell Vaccine Major Product Offerings
7.14.4 Medigene Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Medigene Key News & Latest Developments
7.15 Merck & Co.
7.15.1 Merck & Co. Company Summary
7.15.2 Merck & Co. Business Overview
7.15.3 Merck & Co. Dendritic Cell Vaccine Major Product Offerings
7.15.4 Merck & Co. Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Merck & Co. Key News & Latest Developments
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Company Summary
7.16.2 Northwest Biotherapeutics Business Overview
7.16.3 Northwest Biotherapeutics Dendritic Cell Vaccine Major Product Offerings
7.16.4 Northwest Biotherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Northwest Biotherapeutics Key News & Latest Developments
7.17 Glaxo Smith Kline
7.17.1 Glaxo Smith Kline Company Summary
7.17.2 Glaxo Smith Kline Business Overview
7.17.3 Glaxo Smith Kline Dendritic Cell Vaccine Major Product Offerings
7.17.4 Glaxo Smith Kline Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Glaxo Smith Kline Key News & Latest Developments
7.18 Tella Incorporation
7.18.1 Tella Incorporation Company Summary
7.18.2 Tella Incorporation Business Overview
7.18.3 Tella Incorporation Dendritic Cell Vaccine Major Product Offerings
7.18.4 Tella Incorporation Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Tella Incorporation Key News & Latest Developments
7.19 Vaxil BioTherapeutics
7.19.1 Vaxil BioTherapeutics Company Summary
7.19.2 Vaxil BioTherapeutics Business Overview
7.19.3 Vaxil BioTherapeutics Dendritic Cell Vaccine Major Product Offerings
7.19.4 Vaxil BioTherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 Vaxil BioTherapeutics Key News & Latest Developments
8 Global Dendritic Cell Vaccine Production Capacity, Analysis
8.1 Global Dendritic Cell Vaccine Production Capacity, 2018-2029
8.2 Dendritic Cell Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dendritic Cell Vaccine Supply Chain Analysis
10.1 Dendritic Cell Vaccine Industry Value Chain
10.2 Dendritic Cell Vaccine Upstream Market
10.3 Dendritic Cell Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dendritic Cell Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dendritic Cell Vaccine in Global Market
Table 2. Top Dendritic Cell Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dendritic Cell Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dendritic Cell Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Dendritic Cell Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Dendritic Cell Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dendritic Cell Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Dendritic Cell Vaccine Product Type
Table 9. List of Global Tier 1 Dendritic Cell Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dendritic Cell Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dendritic Cell Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Dendritic Cell Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dendritic Cell Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Dendritic Cell Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dendritic Cell Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Dendritic Cell Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dendritic Cell Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dendritic Cell Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Dendritic Cell Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dendritic Cell Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dendritic Cell Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dendritic Cell Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dendritic Cell Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dendritic Cell Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dendritic Cell Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dendritic Cell Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dendritic Cell Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Dendritic Cell Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dendritic Cell Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dendritic Cell Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dendritic Cell Vaccine Sales, (K Units), 2024-2029
Table 46. 3M Company Summary
Table 47. 3M Dendritic Cell Vaccine Product Offerings
Table 48. 3M Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. 3M Key News & Latest Developments
Table 50. Activarti Company Summary
Table 51. Activarti Dendritic Cell Vaccine Product Offerings
Table 52. Activarti Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Activarti Key News & Latest Developments
Table 54. Argos Therapeutics Company Summary
Table 55. Argos Therapeutics Dendritic Cell Vaccine Product Offerings
Table 56. Argos Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Argos Therapeutics Key News & Latest Developments
Table 58. Batavia Bioservices Company Summary
Table 59. Batavia Bioservices Dendritic Cell Vaccine Product Offerings
Table 60. Batavia Bioservices Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Batavia Bioservices Key News & Latest Developments
Table 62. Bellicum Pharmaceuticals Company Summary
Table 63. Bellicum Pharmaceuticals Dendritic Cell Vaccine Product Offerings
Table 64. Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bellicum Pharmaceuticals Key News & Latest Developments
Table 66. Creagene Company Summary
Table 67. Creagene Dendritic Cell Vaccine Product Offerings
Table 68. Creagene Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Creagene Key News & Latest Developments
Table 70. DanDrit Biotech Company Summary
Table 71. DanDrit Biotech Dendritic Cell Vaccine Product Offerings
Table 72. DanDrit Biotech Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. DanDrit Biotech Key News & Latest Developments
Table 74. DCPrime Company Summary
Table 75. DCPrime Dendritic Cell Vaccine Product Offerings
Table 76. DCPrime Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. DCPrime Key News & Latest Developments
Table 78. Sanpower Corporation (Dendreon Corporation) Company Summary
Table 79. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product Offerings
Table 80. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Sanpower Corporation (Dendreon Corporation) Key News & Latest Developments
Table 82. Elios Therapeutics Company Summary
Table 83. Elios Therapeutics Dendritic Cell Vaccine Product Offerings
Table 84. Elios Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Elios Therapeutics Key News & Latest Developments
Table 86. ImmunoCellular Therapeutics Company Summary
Table 87. ImmunoCellular Therapeutics Dendritic Cell Vaccine Product Offerings
Table 88. ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. ImmunoCellular Therapeutics Key News & Latest Developments
Table 90. Immunicum Company Summary
Table 91. Immunicum Dendritic Cell Vaccine Product Offerings
Table 92. Immunicum Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Immunicum Key News & Latest Developments
Table 94. Kiromic Company Summary
Table 95. Kiromic Dendritic Cell Vaccine Product Offerings
Table 96. Kiromic Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Kiromic Key News & Latest Developments
Table 98. Medigene Company Summary
Table 99. Medigene Dendritic Cell Vaccine Product Offerings
Table 100. Medigene Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Medigene Key News & Latest Developments
Table 102. Merck & Co. Company Summary
Table 103. Merck & Co. Dendritic Cell Vaccine Product Offerings
Table 104. Merck & Co. Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Merck & Co. Key News & Latest Developments
Table 106. Northwest Biotherapeutics Company Summary
Table 107. Northwest Biotherapeutics Dendritic Cell Vaccine Product Offerings
Table 108. Northwest Biotherapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Northwest Biotherapeutics Key News & Latest Developments
Table 110. Glaxo Smith Kline Company Summary
Table 111. Glaxo Smith Kline Dendritic Cell Vaccine Product Offerings
Table 112. Glaxo Smith Kline Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Glaxo Smith Kline Key News & Latest Developments
Table 114. Tella Incorporation Company Summary
Table 115. Tella Incorporation Dendritic Cell Vaccine Product Offerings
Table 116. Tella Incorporation Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Tella Incorporation Key News & Latest Developments
Table 118. Vaxil BioTherapeutics Company Summary
Table 119. Vaxil BioTherapeutics Dendritic Cell Vaccine Product Offerings
Table 120. Vaxil BioTherapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Vaxil BioTherapeutics Key News & Latest Developments
Table 122. Dendritic Cell Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Dendritic Cell Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Dendritic Cell Vaccine Production by Region, 2018-2023 (K Units)
Table 125. Global Dendritic Cell Vaccine Production by Region, 2024-2029 (K Units)
Table 126. Dendritic Cell Vaccine Market Opportunities & Trends in Global Market
Table 127. Dendritic Cell Vaccine Market Drivers in Global Market
Table 128. Dendritic Cell Vaccine Market Restraints in Global Market
Table 129. Dendritic Cell Vaccine Raw Materials
Table 130. Dendritic Cell Vaccine Raw Materials Suppliers in Global Market
Table 131. Typical Dendritic Cell Vaccine Downstream
Table 132. Dendritic Cell Vaccine Downstream Clients in Global Market
Table 133. Dendritic Cell Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dendritic Cell Vaccine Segment by Type in 2022
Figure 2. Dendritic Cell Vaccine Segment by Application in 2022
Figure 3. Global Dendritic Cell Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dendritic Cell Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dendritic Cell Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Dendritic Cell Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dendritic Cell Vaccine Revenue in 2022
Figure 9. By Type - Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Dendritic Cell Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Dendritic Cell Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dendritic Cell Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 23. US Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 37. China Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dendritic Cell Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dendritic Cell Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dendritic Cell Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dendritic Cell Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dendritic Cell Vaccine by Region, 2022 VS 2029
Figure 54. Dendritic Cell Vaccine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の樹状細胞ワクチン市場予測2023-2029：非標的型、標的型] (コード：MMG23LY8450)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の樹状細胞ワクチン市場予測2023-2029：非標的型、標的型]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の不活化ポリオウイルスワクチン市場予測2023-2029：ヒト二倍体細胞、サル腎臓細胞
  • 世界のポリオウイルスワクチン市場予測2023-2029：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）
  • 世界のIPVワクチン市場予測2023-2029：Mahoney株、MEF1株、Saukett株
  • 世界のワクチンモニタリングキット市場予測2023-2029：LN2保管、標準保管、超低温保管
  • 世界の弱毒生水痘ワクチン市場予測2023-2029：一価ワクチン、混合ワクチン

    • ◆H&Iグローバルリサーチのお客様（例）◆